Homepage

Supporting risk research and the dissemination of risk-related knowledge

News

In 2023, the SCOR Corporate Foundation for Science decided to finance the “Aligning competitive morbidities and causes of early onset deaths” for the next four years (2023-2026). The Project is led by Olivier Cussenot, Professor of Urology and Directeur of the Center for Research on Prostatic and Urological Pathologies (ReCePP) in Paris.
The goal of this project is to integrate genetic markers into the estimation of competitive morbidity and mortality from a database – the only one of its kind in the world – of three cohorts of men followed for 20 years. Furthermore, the project aims to define subsets of genetic markers and predictive algorithms that could be useful in personalized screening, intervention, and prevention, and to offer insights on useful strategies for causal inference in prostate diseases.

TSE

The Foundation is part of SCOR's long-term commitment to risk research and the dissemination of risk-related knowledge.

Funded Projects

As its name indicates, the objective of the SCOR Corporate Foundation for Science is to support scientific research. The Foundation may lend its support to various kinds of risk and (re)insurance-related projects, including university chairs, research projects, conferences and publications.
Read more

DNA-molecule-doctor-genetic
Aligning competitive morbidities and causes of early onset deaths
SDU_front_hero-2560x640
SCOR Chair on Mortality Research
mortality_climate_change
Who, When, and Where? Assessing Mortality Risk of Climate Change
Covid19 - Cancer
Estimating the impact of the COVID-19 pandemic on breast cancer
3rd_Alzheimer_prize
Apply for funding
Projects seeking the support of the SCOR Corporate Foundation may be addressed to:

SCOR Corporate Foundation
5, avenue Kléber
75795 Paris Cedex 16
fondation@scor.com